Clinical Trials

Major Depressive Disorder Research Study – Riluzole (H-26581)

Are you between the ages of 18 and 65 and have been diagnosed with major depressive disorder? Baylor College of Medicine is conducting a study that investigates the benefit of Riluzole, a drug that is FDA approved for Lou Gehrig's disease (ALS) in combination with a standard antidepressant medication. The study is sponsored by the National Institutes of Health, and is being conducted at four sites nationwide. You may be compensated for your participation.  All inquiries are confidential.